ANCA Vasculitis Highlights

Highlighted Article:   RAVE Trial (Rituximab for ACNA Vasculitis) demonstrated that Rituximab was non-inferior to Cyclophosphamide therapy for ANCA Vasculitis, which includes renal outcomes.

Highlighted Fact: Mononeuritis multiplex (a vasculitic neuropathy) is most often a manifestation of a vasculitis (particularlly EGPA, Polyarteritis nodosa, GPA).

Highlighted Clinical Lesson: The value of a detailed chart review - allowed this team to identify the gap in this patient's extensive work up and ordered an ANCA!